Researchers who once relied on whole-genome sequencing (WGS) for reliable variant information are now turning to WES for its faster turnaround time and cost-effectiveness. Considerable evidence is emerging that applying WES in clinical research settings will lead to improved diagnosis and, in some cases, treatment of genetic disease. WES may improve patient health outcomes and facilitate the more efficient use of healthcare resources.